07/10/2017

NCCN has published updates to the NCCN Guidelines® and NCCN Compendium® for Malignant Pleural Mesothelioma

NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) and NCCN Drugs & Biologics Compendium (NCCN Compendium^®) for Malignant Pleural Mesothelioma. These NCCN Guidelines^® are currently available as Version 2.2017. 

• Principles of Systemic Therapy (MPM-A 1 of 2)
  • Second-line Chemotherapy changed to Subsequent Systemic Therapy
    • Nivolumab ± ipilimumab added as a treatment option.
    • Pembrolizumab added as a treatment option.
    • References 16 and 17 added.

*For your reference, the previous update (Version 1.2017) to the NCCN Guidelines for Malignant Pleural Mesothelioma, published on March 2, 2017 is available at the following link: https://www.nccn.org/professionals/physician_gls/pdf/mpm.pdf